In the Contemporary Outcomes after Surgery and Medical Treatment in Patients with Severe Aortic Stenosis (CURRENT AS) Registry enrolling 3815 consecutive patients with severe AS, there were 628 patients with moderate or severe TR (TR group) and 3187 patients with no or mild TR (no TR group). The study patients were subdivided into the initial aortic valve replacement (AVR) stratum (n = 1197) and the conservative stratum (n = 2618) according to treatment strategy. The primary outcome measure was a composite of aortic valve-related death or hospitalization due to heart failure. The 5-year freedom rate from the primary outcome measure was significantly lower in the TR group than in the no TR group (49.1% vs. 67.3%, P < 0.001). Even after adjusting for confounders, the excess risk of TR relative to no TR for the primary outcome measure remained significant [hazard ratio (HR): 1.25, 95% confidence interval (CI): 1.06-1.48; P = 0.008]. The trend for the excess adjusted risk in the TR group was consistent in the initial AVR and the conservative strata (HR 1.55, 95% CI: 0.97-2.48; P = 0.07; HR 1.22, 95% CI: 1.02-1.46; P = 0.03, respectively). In the initial AVR stratum, the 5-year freedom rate from the primary outcome measure was not different between the two groups with (n = 56) or without (n = 91) concomitant tricuspid annuloplasty (61.5% vs. 72.1%, P = 0.48).
Introduction
Aortic stenosis (AS) is the most common valvular heart disease with an increasing prevalence in the elderly population, associated with a poor prognosis and complex pathophysiology. 1 Tricuspid regurgitation (TR) is also a common echocardiographic finding, 2 especially in the elderly population. TR is considered benign, unless it is associated with significant pulmonary hypertension and/or right or left ventricular dysfunction. 3, 4 The prognostic impact of TR depends on the severity of underlying heart failure. 4, 5 Takahashi et al. 6 reported that the prognosis of severe isolated TR associated with atrial fibrillation was favourable in terms of cardiac death. In contrast, Nath et al. 7 reported that increasing severity of TR was associated with worse survival in various heart diseases, regardless of the left ventricular ejection fraction or pulmonary artery pressure. After publication of this previous study, TR has been attracting an increasing amount of attention in various heart diseases. A recent study also suggested that severe isolated TR is associated with excess mortality and morbidity. 8 Functional TR is commonly associated with severe AS. However, previous studies on the prognostic impact of TR concomitant with AS are limited. 9, 10 Additionally, there are no definite data on the clinical significance of TR in patients with severe AS. Therefore, we aimed to investigate the prognostic impact of clinically significant TR in patients with severe AS.
Methods

Study population
The The study patients were subdivided into the initial aortic valve replacement (AVR) stratum (n = 1197) and the conservative stratum (n = 2618) according to treatment strategy selected after the index echocardiography ( Figure 1) . Baseline characteristics and long-term clinical outcomes were compared between patients with moderate or severe TR (TR group) and patients with no or mild TR (no TR group) at the index echocardiography. The prognostic impact of having moderate or severe TR was evaluated in the entire study population, and in the two strata based on the initial treatment strategies. The severity of TR was assessed using an integrated approach and graded as none, mild, moderate, and severe Figure 1 Flowchart of the patients. From a study population of 3815 patients with severe aortic stenosis who were enrolled in the CURRENT AS according to current guidelines. 13, 14 Moreover, in the initial AVR stratum, the effect of concomitant tricuspid annuloplasty on the primary outcome measure was evaluated.
The institutional review board of all 27 participating centres approved the protocol. Written informed consent was waived because of the retrospective nature of the study, and no patients refused to participate in the study when contacted for follow-up.
Data collection and follow-up
Collection of baseline clinical information was conducted through hospital chart or database review. Follow-up data were mainly collected through review of hospital charts or collected through contact with patients, relatives, and/or referring physicians using mail with questions regarding survival, symptoms, and subsequent hospitalizations.
Endpoints
The primary outcome measure for the present analysis was a composite of aortic valve-related death or hospitalization due to heart failure. Aortic valve-related death was defined as aortic procedure-related death, sudden cardiac death, or death due to heart failure considered to be related to AS. Other definitions of the clinical events were described previously.
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Statistical analysis
Categorical variables are presented as numbers and percentages, and were compared using the v 2 test. Continuous variables are expressed as the mean ± standard deviation or median with interquartile range, and were compared using the Student's t-test. With the exception of age, continuous variables were dichotomized by median values or clinically meaningful reference values. Binary logistic regression analysis was performed to evaluate the associated factors of moderate or severe TR by using the 22 variables listed in Table 1 . We used the Kaplan-Meier method to estimate the freedom rate from the primary outcome and assessed the differences between the TR and the no TR groups with the log-rank test. These analyses were separately conducted in the initial AVR stratum and the conservative stratum, as well as the entire cohort. We also divided patients in the TR group among the initial AVR stratum into two groups according to concomitant tricuspid annuloplasty at the time of AVR. This was performed to assess the prognostic impact of having tricuspid annuloplasty on the primary outcome. Cox proportional hazard models were used to estimate the hazard ratio (HR) of the TR group compared with the no TR group in the entire cohort, the initial AVR stratum, and the conservative stratum separately. We constructed multivariable Cox proportional hazard models with the 22 risk-adjusting variables in Table 1 to estimate the adjusted HRs, consistent with our previous report. 11 Statistical analyses were performed using SPSS Statistics for Windows (ver. 22.0; IBM, Armonk, NY, USA). All reported P-values were two-tailed, and P-values <0.05 were considered statistically significant.
Results
Baseline clinical and echocardiographic characteristics and associated factors of moderate or severe TR Among 3815 patients, 628 (16%) patients had moderate or severe TR (TR group) at the index echocardiography. In the TR group, there were 147 patients in the initial AVR stratum and 481 patients in the conservative stratum. A total of 3187 patients had no or mild TR (no TR group). In the no TR group, there were 1050 patients in the initial AVR stratum and 2137 patients in the conservative stratum ( Figure 1) . TR and the no TR groups ( Table 1) . Patients in the TR group were older, and more often had symptoms related to AS, atrial fibrillation, and anaemia (P < 0.001, respectively) than those in the no TR group. With regard to the echocardiographic severity of AS, there was no significant difference in the AVA index between the two groups. However, V max and the mean pressure gradient were higher (P < 0.001, respectively) in the no TR group than in the TR group ( Table 1) . In multivariable logistic regression analysis, the factors related to the presence of clinically significant TR included old age, small body mass index, female sex, atrial fibrillation or flutter, any combined valvular disease except for TR, and a TR pressure gradient >40 mmHg. Factors related to the absence of TR included hypertension, coronary artery disease, and V max > _4 m/s ( Table 2) .
Clinical outcomes in the entire study population
The median follow-up duration was 1123 days (interquartile range: 559-1577 days). The 5-year freedom rate from the primary outcome measure (a composite of aortic valve-related death or hospitalization due to heart failure) was significantly lower in the TR group than in the no TR group (49.1% vs. 67.3%, P < 0.001) (Figure 2A ). Even after adjusting for confounders, the excess risk of the TR group relative to the no TR group remained highly significant [HR: 1.25, 95% confidence interval (CI): 1.06-1.48; P = 0.008] ( Table 3) .
Clinical outcomes in the initial AVR stratum
The 5-year freedom rate from the primary outcome measure was significantly lower in the TR group than in the no TR group (69.3% vs. 85.5%, P < 0.001) ( Figure 2B ). After adjusting for confounders, the excess risk for the primary outcome measure tended to be higher in the TR group compared with the no TR group (HR: 1.55, 95% CI: 0.97-2.48; P = 0.07) ( Table 3 ). The excess adjusted risk in the TR group relative to the no TR group for aortic valve-related death was significant (HR: 2.08, 95% CI: 1.03-4.19; P = 0.04) ( Table 3) . Among 147 patients in the TR group, 56 underwent tricuspid annuloplasty and 91 did not. The 5-year freedom rate from the primary outcome measure was not significantly different between the two groups (5-year freedom rate: 61.5% vs. 72.1%, P = 0.48) (Figure 3) .
Clinical outcomes in the conservative stratum
The 5-year freedom rate from the primary outcome measure was significantly lower in the TR group than in the no TR group (42.5% vs. 57.7%, P < 0.001) ( Figure 2C ). Even after adjusting for confounders, the excess risk of the TR group relative to the no TR group remained significant (HR: 1.22, 95% CI: 1.02-1.46; P = 0.03) ( Table 3) .
Discussion
In the present study, we assessed the impact of clinically significant TR on the long-term outcomes in patients with severe AS. There were three main findings: (i) clinically significant TR was independently associated with a higher risk for the primary outcome measure in patients with severe AS, even after adjusting for cofounders, (ii) an association between clinically significant TR and poor long-term outcome was observed, regardless of the initial treatment strategy, and (iii) concomitant tricuspid annuloplasty at the time of AVR did not have an impact on the primary outcome measure in patients with clinically significant TR.
Associated factors of moderate or severe TR in patients with severe AS
In the present study, 16% of patients with severe AS showed clinically significant TR. This rate is consistent with a previous report. 15 Atrial fibrillation, any combined valvular disease except TR, and the TR pressure gradient were highly associated with moderate or severe TR. The presence of atrial fibrillation is a strong predictor of TR, 16, 17 and atrial fibrillation has a high prevalence in patients with severe AS. 18 In the present study, approximately half of the patients with moderate or severe TR had atrial fibrillation or flutter, and the presence of atrial fibrillation was a strong independent factor of occurrence of clinically significant TR in patients with severe AS. In patients with severe AS, left ventricular hypertrophy is induced by pressure overload, resulting in left ventricular diastolic dysfunction. Left ventricular diastolic dysfunction may induce pulmonary hypertension, resulting in remodelling of the right ventricle, tricuspid annular dilatation tricuspid valve tethering, and clinically significant TR. Igarashi et al. 20 reported that persistent severe diastolic dysfunction after AVR for severe AS was an important factor of postoperative progression of TR. In the present study, there was no difference in the AVA index between the TR and the no TR groups. However, the degree of left ventricular hypertrophy and left ventricular diastolic dysfunction may be different, even with the same severity of AS. Left ventricular diastolic dysfunction may have a significant relation with the occurrence of TR in patients with severe AS.
Impact of clinically significant TR on prognosis of patients with severe AS
In the present study, moderate or severe TR was associated with a poorer prognosis independent of comorbidities, AS severity, and the initial treatment strategy. An association between clinically significant TR and a poor outcome has been shown in patients with various valvular diseases 7 or low-flow low-gradient AS. The underlying mechanisms related to a poor outcome in patients with clinically significant TR are still unclear. Previous studies have reported that the presence of TR may reflect right ventricular dysfunction, and underlying right ventricular dysfunction is associated with a poor outcome. 4, 7 Concomitant mitral valve diseases, left ventricular diastolic dysfunction, pulmonary hypertension, and/or atrial fibrillation are frequently observed in patients with severe AS, and these may also cause TR. Clinically significant TR may be the result of these multiple factors caused by severe AS. Therefore, TR might be a surrogate marker of prognosis of patients with severe AS. 
Impact of TR on prognosis in patients with the initial AVR stratum
Progression of isolated TR after mitral valve surgery is well known. 17, 21 Therefore, concomitant tricuspid valve repair is recommended in patients with clinically significant TR or tricuspid annular dilatation, despite mild TR at the time of mitral valve surgery. 22, 23 However, the incidence of clinically significant TR and tricuspid annular dilatation is lower in patients with AS than in those with mitral valve disease. Dumont et al. 24 reported recently that post-operative TR grade had worsened in 26.7% of severe AS patients who underwent surgical or transcatheter AVR alone, and only tricuspid annulus size >40 mm was an independent echocardiographic predictor of postoperative significant TR. On the other hand, there are still few data on the post-operative clinical course and outcomes in patients with severe AS concomitant with clinically significant TR.
In the present study, the presence of clinically significant TR preoperatively was related to a poor outcome after AVR, while tricuspid annuloplasty at the time of AVR did not affect the primary outcomes. This observation might strengthen the hypothesis that TR is a surrogate marker of poor prognosis in patients with severe AS in whom multiple associated factors (e.g. severe left ventricular diastolic dysfunction, mitral valve diseases, pulmonary hypertension, and/or atrial fibrillation) might persist, even if tricuspid annuloplasty is performed.
Study limitations
The main limitation of the present study is the retrospective design. Therefore, we could not exclude inherent bias, particularly selection bias in the comparison between the initial AVR and the conservative strata. There also might have been unmeasured confounders for the poor prognosis of patients with TR. Second, the number of patients who were analysed for the effect of concomitant tricuspid annuloplasty at the time of AVR was relatively small. Furthermore, the present study was conducted using multicentre registry data obtained from the CURRENT AS. Therefore, the indication for tricuspid annuloplasty concomitant with AVR may differ depending on the institutions. A randomized study is required to investigate whether tricuspid annuloplasty can improve outcome in patients with severe AS and clinically significant TR. Third, echocardiographic analysis was not performed in the core laboratory, but performed in individual centres. TR grade was not quantified, and semi-quantitative measurement of the severity TR based on TR jet area was used. Aortic valve-related death included aortic procedure-related death, sudden death, and death due to heart failure. Hospitalization due to heart failure was defined as hospitalization due to worsening heart failure requiring intravenous drug therapy. For the endpoint of sudden death in the initial AVR stratum, we did not perform adjusted analysis because of the small number of events. AVR, aortic valve replacement; CI, confidence interval; HR, hazard ratio; TR, tricuspid regurgitation. 
Conclusions
The presence of clinically significant TR concomitant with severe AS is associated with a poor long-term outcome, regardless of the initial treatment therapeutic strategy. Figure 3 Effect of concomitant tricuspid annuloplasty on the primary outcome measure in patients with moderate or severe TR who were managed with the initial AVR strategy. Kaplan-Meier curves for the freedom rate from the primary outcome measure between patients with and without concomitant TAP in the initial AVR stratum and in the TR group (moderate or severe TR). AVR, aortic valve replacement; HF, heart failure; TAP, tricuspid annuloplasty; TR, tricuspid regurgitation.
